NavaDerm Partners, headquartered in New York City, is a Northeast-based dermatology management platform formed through the partnership of five dermatology groups in New York and New Jersey. 

New York City dermatologist Roy Geronemus, MD is NavaDerm Partners’ new Chief Executive Officer.

Dr. Geronemus graduated from Harvard University and pursued his medical education at the University of Miami School of Medicine where he is a member of the school's Alumni Hall of Fame. He trained in dermatology at the New York University Medical Center where he was the chief resident and subsequently underwent a fellowship training in Mohs Micrographic Surgery and Cutaneous Oncology. He founded the Laser & Skin Surgery Center of New York (LSSCNY) in 1993. LSSCNY partnered with NavaDerm in August 2019. He is a Clinical Professor of Dermatology at New York University Medical Center where he founded its laser program and served nine years as chief of dermatologic and laser surgery. He is past president of the American Society for Dermatologic Surgery and the American Society for Laser Medicine & Surgery. Dr. Geronemus is the Chairman of the Board of the New York Stem Cell Foundation.

“For years Dr. Geronemus has led an outstanding group of physicians and their dedicated staff at LSSCNY, one of the largest independent dermatology practices in the northeast, and we could not pick a better leader for the NavaDerm platform,” says Inder Tallur, Sr. Managing Director of BelHealth Investment Partners and Director of NavaDerm, in a news release. “Dr. Geronemus' vision and expertise in the dermatology sectors will help drive growth and unlock value for all stakeholders. We remain focused on our initial thesis of exclusively partnering with physician founders and expect several more to join the platform under Dr. Geronemus' leadership."

Dr. Geronemus adds, "I am thrilled to join the NavaDerm team. With truly exceptional physicians leading their individual practices, NavaDerm has become a preeminent Northeast-based dermatology platform in less than two years. While I will continue to practice full-time and serve my patients, I also look forward to bringing my experience as a physician and executive to NavaDerm to drive the best clinical outcomes and grow the platform with Inder and the BelHealth team."

NavaDerm Partners, headquartered in New York City, is a Northeast-based dermatology management platform formed through the partnership of five dermatology groups in New York and New Jersey. Operating out of seven locations, NavaDerm's mission is to support its 50+ board-certified dermatologists and their dedicated staffs in providing outstanding patient care. NavaDerm's clinicians provide world-class and comprehensive general dermatology services across medical, surgical and cosmetic procedures. BelHealth Investment Partners is a healthcare private equity firm focused on lower middle market companies. The firm invests across three core healthcare segments: Services, Products and Distribution. BelHealth is investing from its current $350 million fund.